Medical oncology faculty promotions 2014
July 1, 2014 · Comments Off
Four University of Colorado Cancer Center investigators and Department of Medical Oncology faculty were recently...
Results in Phase I Trial of OMP-54F28, a Wnt Inhibitor Targeting Cancer Stem Cells
May 31, 2014 · Comments Off
Phase 1 clinical trial results presented at ASCO 2014 pave way for cancer stem cell drug, OMP-54F28, in new clinical trials for pancreatic, ovarian, and hepatocellular cancers.
AACR News: Rigosertib Phase 1 results lead to disease-focused Phase 2 development
April 9, 2013 · Comments Off
Results of a phase 1 clinical trial reported at the American Association for Cancer Research (AACR) annual conference show that orally administered Rigosertib is well tolerated in patients with advanced solid tumors. This is the first trial in which orally administered Rigosertib, a dual kinase inhibitor, was studied in solid tumors. Intravenously rigosertib is already in phase 3 clinical trials for myelodysplastic syndrome and pancreatic cancer and oral rigosertib is being studied in a pair of Phase II trials in lower-risk transfusion dependent MDS patients. The drug candidate is being developed by Onconova Therapeutics, Inc., of Pennington, NJ.
That dude is tough as nails
May 30, 2012 · Comments Off
No sore throat should last a year and a half. Tim Elliott tried antibiotics and...
“It’s now a part of our family history”
April 23, 2012 · Comments Off
Blindsided by multiple cancer diagnoses in one year, family and friends decide to do something...
A five-year dispute over Gardasil, a vaccine that protects against human papillomavirus (HPV), just got...
NIH funds first cancer stem cell clinical trial at University of Colorado Cancer Center
September 19, 2011 · Comments Off
The National Institute of Health recently awarded University of Colorado Cancer Center investigator Antonio Jimeno...
Phase I trial of promising anti-cancer drug CUDC-101 opens with first patient treated at CU Cancer Center
August 18, 2011 · Comments Off
The University of Colorado Cancer Center has treated the first patient with a promising cancer-fighting...
The tale of the tongue
June 9, 2011 · Comments Off
Editor’s note: Mark Grogan is a head and neck cancer patient at the University of...
amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado Cancer Survivorship clinical trial colon cancer colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu enzalutamide fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Remember! "Cancer: The Emperor of All Maladies" starts tonight at 8. You will not want to miss this! ow.ly/KZ956